Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Citations
    • ABNT:
      ABO, Y.-N. et al. Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use. Pediatric Infectious Disease Journal, [s. l.], v. 39, n. 4, p. e42, 2020. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=142770534. Acesso em: 24 set. 2020.
    • AMA:
      Abo Y-N, Curtis N, Butters C, Rozen TH, Marais BJ, Gwee A. Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use. Pediatric Infectious Disease Journal. 2020;39(4):e42. Accessed September 24, 2020. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=142770534
    • APA:
      Abo, Y.-N., Curtis, N., Butters, C., Rozen, T. H., Marais, B. J., & Gwee, A. (2020). Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use. Pediatric Infectious Disease Journal, 39(4), e42.
    • Chicago/Turabian: Author-Date:
      Abo, Yara-Natalie, Nigel Curtis, Coen Butters, Thomas H. Rozen, Ben J. Marais, and Amanda Gwee. 2020. “Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use.” Pediatric Infectious Disease Journal 39 (4): e42. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=142770534.
    • Harvard:
      Abo, Y.-N. et al. (2020) ‘Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use’, Pediatric Infectious Disease Journal, 39(4), p. e42. Available at: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=142770534 (Accessed: 24 September 2020).
    • Harvard: Australian:
      Abo, Y-N, Curtis, N, Butters, C, Rozen, TH, Marais, BJ & Gwee, A 2020, ‘Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use’, Pediatric Infectious Disease Journal, vol. 39, no. 4, p. e42, viewed 24 September 2020, .
    • MLA:
      Abo, Yara-Natalie, et al. “Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use.” Pediatric Infectious Disease Journal, vol. 39, no. 4, Apr. 2020, p. e42. EBSCOhost, search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=142770534.
    • Chicago/Turabian: Humanities:
      Abo, Yara-Natalie, Nigel Curtis, Coen Butters, Thomas H. Rozen, Ben J. Marais, and Amanda Gwee. “Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use.” Pediatric Infectious Disease Journal 39, no. 4 (April 2020): e42. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=142770534.
    • Vancouver/ICMJE:
      Abo Y-N, Curtis N, Butters C, Rozen TH, Marais BJ, Gwee A. Successful Treatment of a Severe Vision-Threatening Paradoxical Tuberculous Reaction with Infliximab: First Pediatric Use. Pediatric Infectious Disease Journal [Internet]. 2020 Apr [cited 2020 Sep 24];39(4):e42. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=142770534